Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Lefebvre

Showing results (21-30 of 352) with videos related to

Pageof 36
Sort By:
The Journal of Allergy and Clinical Immunology. in Practice|November 16, 2013
Association between consistent omalizumab treatment and asthma controlMarie-Hélène Lafeuille, Jonathan Gravel, Jie Zhang, et al.
Current Medical Research and Opinion|July 26, 2023
Access and real-world use patterns of esketamine nasal spray among patients with treatment-resistant depression covered by private or public insuranceAmanda Teeple, Maryia Zhdanava, Dominic Pilon, et al.
Current Medical Research and Opinion|October 7, 2006
Relationship between hemoglobin level and quality of life in anemic patients with chronic kidney disease receiving epoetin alfaPatrick Lefebvre, Francis Vekeman, Brenda Sarokhan, et al.
Journal of Medical Economics|December 16, 2011
Utilization and cost comparison of erythropoiesis-stimulating agents in inpatient and outpatient hospital settingsMarie-Hélène Lafeuille, Robert A Bailey, Francis Vekeman, et al.
Disease Management : DM|February 21, 2007
The economic impact of epoetin alfa therapy on delaying time to dialysis in elderly patients with chronic kidney diseasePatrick Lefebvre, Mei Sheng Duh, Samir H Mody, et al.
Cancer|January 20, 2009
An assessment of erythroid response to epoetin alpha as a single agent versus in combination with granulocyte- or granulocyte-macrophage-colony-stimulating factor in myelodysplastic syndromes using a meta-analysis approachSuneel Mundle, Patrick Lefebvre, Francis Vekeman, et al.
Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery|March 12, 2017
Body composition changes in the first month after sleeve gastrectomy based on gender and anatomic siteLaurent Maïmoun, Patrick Lefebvre, Audrey Jaussent, et al.
Plos One|April 6, 2018
Adherence to rivaroxaban versus apixaban among patients with non-valvular atrial fibrillation: Analysis of overall population and subgroups of prior oral anticoagulant usersColleen A McHorney, Concetta Crivera, François Laliberté, et al.
Current Medical Research and Opinion|April 14, 2018
Economic burden of treatment failure in chronic lymphocytic leukemia patientsSong Wang, Marie-Hélène Lafeuille, Patrick Lefebvre, et al.
Current Medical Research and Opinion|January 28, 2020
Use of home health and other healthcare delivery pathways among privately insured patients with and without treatment-resistant depressionDominic Pilon, Holly Szukis, David Singer, et al.
Pageof 36

Showing results (21-30 of 352) with videos related to

Sort By:
Pageof 36
The Journal of Allergy and Clinical Immunology. in Practice|November 16, 2013
Association between consistent omalizumab treatment and asthma controlMarie-Hélène Lafeuille, Jonathan Gravel, Jie Zhang, et al.
Current Medical Research and Opinion|July 26, 2023
Access and real-world use patterns of esketamine nasal spray among patients with treatment-resistant depression covered by private or public insuranceAmanda Teeple, Maryia Zhdanava, Dominic Pilon, et al.
Current Medical Research and Opinion|October 7, 2006
Relationship between hemoglobin level and quality of life in anemic patients with chronic kidney disease receiving epoetin alfaPatrick Lefebvre, Francis Vekeman, Brenda Sarokhan, et al.
Journal of Medical Economics|December 16, 2011
Utilization and cost comparison of erythropoiesis-stimulating agents in inpatient and outpatient hospital settingsMarie-Hélène Lafeuille, Robert A Bailey, Francis Vekeman, et al.
Disease Management : DM|February 21, 2007
The economic impact of epoetin alfa therapy on delaying time to dialysis in elderly patients with chronic kidney diseasePatrick Lefebvre, Mei Sheng Duh, Samir H Mody, et al.
Cancer|January 20, 2009
An assessment of erythroid response to epoetin alpha as a single agent versus in combination with granulocyte- or granulocyte-macrophage-colony-stimulating factor in myelodysplastic syndromes using a meta-analysis approachSuneel Mundle, Patrick Lefebvre, Francis Vekeman, et al.
Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery|March 12, 2017
Body composition changes in the first month after sleeve gastrectomy based on gender and anatomic siteLaurent Maïmoun, Patrick Lefebvre, Audrey Jaussent, et al.
Plos One|April 6, 2018
Adherence to rivaroxaban versus apixaban among patients with non-valvular atrial fibrillation: Analysis of overall population and subgroups of prior oral anticoagulant usersColleen A McHorney, Concetta Crivera, François Laliberté, et al.
Current Medical Research and Opinion|April 14, 2018
Economic burden of treatment failure in chronic lymphocytic leukemia patientsSong Wang, Marie-Hélène Lafeuille, Patrick Lefebvre, et al.
Current Medical Research and Opinion|January 28, 2020
Use of home health and other healthcare delivery pathways among privately insured patients with and without treatment-resistant depressionDominic Pilon, Holly Szukis, David Singer, et al.
Pageof 36